Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04261751 · ClinicalTrials.gov registry record
Moral Injury Symptom Scale/Moral Injury Outcome Scale
A clinical trial of Depression and Anxiety, sponsored by AdventHealth.
- Completed
- Registry status
- 483
- Enrollment target
- 1
- Study location
NCT04261751: Completed study of Depression and Anxiety, sponsored by AdventHealth.
NCT04261751 is a study of Depression and Anxiety that has completed, run by AdventHealth. The registered enrollment target is 483 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04261751, a study of Depression and Anxiety, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 483 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to validate the moral injury symptom scale clinician version short form and the Moral Injury Outcome Scale in nurses. Participants will be recruited in accordance with AdventHealth Policy # 400.120: Selection and Enrollment of AdventHealth Employees, Physicians, and Volunteers for research Studies. Employee participants will be assured participation in this study will not affect performance evaluation or employment-related decisions by peers or supervisors. No employees will be recruited by a direct supervisor. Recruitment of potential employees as participants will occur without coercion by the Principal Investigator (PI), by bulletin board advertisements, or through a third party unassociated in a power/supervisory relationship with the employee (i.e., researchers from Center for Whole-Person Research).
Primary Outcome
measured by the Moral Injury Outcome Scale \& functional outcomes (23 items), and the Moral Injury Symptom Scale - Clinician Version - Short Form (MISS-CV-SF) 11 items. The scale is 10 - 100 with the higher number being worse.
Conditions Studied
Interventions
- OTHER Clinician Questionnaire
Study Locations (1)
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2023-02-07 |
What the finished NCT04261751 record still lists
NCT04261751 is an observational study that tracks outcomes without assigning an intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (39% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Clinician Questionnaire is the first listed.
NCT04261751 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04261751 about?
NCT04261751 is a clinical study titled "Moral Injury Symptom Scale/Moral Injury Outcome Scale". The purpose of this research is to validate the moral injury symptom scale clinician version short form and the Moral Injury Outcome Scale in nurses. Participants will be recruited in accordance with AdventHealth Policy # 400.120: Selection and Enrollment of AdventHealth Employees, Physicians, and V...
What is the current status of trial NCT04261751?
This trial is currently completed. The enrollment target is 483 participants. The study started on 2019-11-01. Estimated completion is 2023-02-07.
What conditions does trial NCT04261751 study?
This clinical trial studies the following conditions: Depression, Anxiety, Burnout, Moral Injury.
What interventions are being tested in trial NCT04261751?
The interventions under investigation include: Clinician Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04261751?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04261751 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04261751's enrollment target sits among peer trials
483 92nd of 679 higher than 588 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy